
Levecon 500 Tablet
Marketer
Consern Pharma Limited
Salt Composition
Levetiracetam (500mg)
Overview Levecon 500 Tablet
Epileptic seizures are managed with the anticonvulsant Levecon 500mg tablets. These tablets may be used as monotherapy or in combination with other medications. Continuous use is crucial for sustained seizure control. Levecon 500mg works by reducing abnormal brain electrical activity. Administration with or without food is acceptable; however, consistent daily timing optimizes efficacy. Dosage is personalized based on individual response and condition, determined by your physician. Long-term therapy is typically recommended; discontinuation or missed doses risk increased seizure frequency. Common side effects, often diminishing after initial weeks, include drowsiness, headache, irritability, altered behavior (including aggression), and reduced appetite. While many side effects resolve without intervention, some warrant medical attention. Suicidal ideation has been reported in a small subset of patients; report any mood deterioration immediately. Prior to commencing treatment, inform your doctor of any pre-existing kidney disease, depression, suicidal tendencies, pregnancy, pregnancy plans, or breastfeeding. Regular blood tests to monitor kidney function may be recommended during treatment.
Uses of Levecon 500 Tablet
Managing Epileptic Seizures
Major Benefits of Levecon 500 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; do not crush, chew, or break it. Levecon 500 Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Levecon 500 Tablet:
- Sleepiness
- Dizziness
- Fatigue
- Headache
- Decreased appetite
- Behavioral changes
- Aggressive behavior
- Irritation
- Agitation
- Nasal congestion (stuffy nose)
- Infection
- Convulsion
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Nausea
- Tremors
- Vertigo
- Lethargy
How to use Levecon 500 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Levecon 500 Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, however, consistent timing is recommended.
How Levecon 500 Tablet works:
Levecon 500 Tablets function as an anticonvulsant, targeting particular receptor sites (SV2A) within neuronal membranes. This action inhibits aberrant neuronal firing in the brain, thereby preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Levecon 500 Tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnant individuals can generally use Levecon 500 Tablet safely; research indicates minimal or negligible fetal risk.
Breast feedingSAFE IF PRESCRIBED
Employing Levecon 500 Tablet while breastfeeding is likely safe. Available human data indicate minimal risk to the infant. Observe the infant for drowsiness and satisfactory weight increase.
DrivingUNSAFE
Taking Levecon 500 Tablets may cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Caution is advised when administering Levecon 500 Tablets to individuals with impaired renal function. Dosage modification for Levecon 500 Tablets may be necessary; physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Levecon 500 Tablet in patients with liver disease appears to be generally safe. Existing evidence indicates dose modification might not be necessary for most individuals. Nonetheless, physician consultation is recommended. Patients experiencing severe hepatic impairment may benefit from a reduced dosage.
What if you forget to take Levecon 500 Tablet :
Should you forget a Levecon 500 Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Levecon 500 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Pyrrolidinone-Acetamide Compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Behavioral Class | AED: A protein ligand within synaptic vesicle 2 |
